BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177,673,632 | -24.1% | 4,707,831 | -8.4% | 0.02% | -21.7% |
| Q2 2023 | $234,115,543 | -55.7% | 5,138,618 | -60.5% | 0.02% | -59.6% |
| Q1 2023 | $528,185,328 | -65.0% | 13,022,319 | -56.0% | 0.06% | -66.7% |
| Q4 2022 | $1,509,431,709 | -6.5% | 29,614,118 | -1.2% | 0.17% | -22.3% |
| Q3 2022 | $1,614,020,000 | -17.0% | 29,966,965 | -1.0% | 0.22% | -12.7% |
| Q2 2022 | $1,944,000,000 | -12.6% | 30,266,194 | +5.5% | 0.25% | -16.0% |
| Q1 2022 | $2,225,497,000 | -8.6% | 28,701,281 | +1.1% | 0.30% | -0.3% |
| Q4 2021 | $2,435,967,000 | +8.6% | 28,377,977 | +1.8% | 0.30% | -0.3% |
| Q3 2021 | $2,242,032,000 | +8.1% | 27,875,555 | +8.2% | 0.30% | +10.2% |
| Q2 2021 | $2,074,731,000 | -1.6% | 25,773,055 | +3.1% | 0.27% | -11.6% |
| Q1 2021 | $2,108,598,000 | +9.2% | 25,001,166 | +3.9% | 0.31% | +4.0% |
| Q4 2020 | $1,931,322,000 | +0.8% | 24,069,317 | +1.0% | 0.30% | -19.7% |
| Q3 2020 | $1,915,945,000 | +13.9% | 23,824,224 | +21.9% | 0.37% | -0.3% |
| Q2 2020 | $1,682,139,000 | +6.7% | 19,537,042 | +0.7% | 0.37% | -13.1% |
| Q1 2020 | $1,575,901,000 | +4.5% | 19,410,034 | +7.6% | 0.43% | +21.9% |
| Q4 2019 | $1,508,082,000 | -2.2% | 18,034,953 | +2.3% | 0.35% | -14.0% |
| Q3 2019 | $1,542,486,000 | +9.8% | 17,634,457 | +2.8% | 0.41% | +9.1% |
| Q2 2019 | $1,404,937,000 | +6.3% | 17,154,303 | +5.5% | 0.37% | 0.0% |
| Q1 2019 | $1,322,021,000 | +37.1% | 16,259,024 | +11.0% | 0.37% | +29.4% |
| Q4 2018 | $964,399,000 | +18.3% | 14,652,081 | +38.6% | 0.29% | +41.7% |
| Q3 2018 | $814,880,000 | +284.1% | 10,570,520 | +267.9% | 0.20% | +257.9% |
| Q2 2018 | $212,161,000 | +135.9% | 2,873,253 | +107.8% | 0.06% | +128.0% |
| Q1 2018 | $89,949,000 | -7.5% | 1,382,966 | -8.0% | 0.02% | -7.4% |
| Q4 2017 | $97,195,000 | +20.2% | 1,503,653 | +16.7% | 0.03% | +12.5% |
| Q3 2017 | $80,883,000 | -35.5% | 1,288,953 | -37.8% | 0.02% | -36.8% |
| Q2 2017 | $125,486,000 | -15.6% | 2,072,797 | -27.7% | 0.04% | +65.2% |
| Q1 2017 | $148,676,000 | -26.7% | 2,866,822 | -37.3% | 0.02% | -30.3% |
| Q4 2016 | $202,716,000 | +254.7% | 4,571,834 | +280.8% | 0.03% | +65.0% |
| Q3 2016 | $57,144,000 | -6.8% | 1,200,477 | -11.5% | 0.02% | -9.1% |
| Q2 2016 | $61,340,000 | +7.6% | 1,356,458 | -2.3% | 0.02% | 0.0% |
| Q1 2016 | $57,015,000 | -44.2% | 1,387,909 | -48.2% | 0.02% | -40.5% |
| Q4 2015 | $102,172,000 | -55.5% | 2,678,143 | -61.6% | 0.04% | -56.5% |
| Q3 2015 | $229,402,000 | -7.8% | 6,983,299 | +96.2% | 0.08% | -1.2% |
| Q2 2015 | $248,904,000 | +26.3% | 3,559,333 | +23.7% | 0.09% | +17.8% |
| Q1 2015 | $197,110,000 | -30.9% | 2,877,545 | -26.0% | 0.07% | -29.8% |
| Q4 2014 | $285,149,000 | -17.5% | 3,890,690 | -19.2% | 0.10% | -21.8% |
| Q3 2014 | $345,684,000 | -3.6% | 4,816,572 | -2.9% | 0.13% | -5.7% |
| Q2 2014 | $358,681,000 | -20.1% | 4,961,024 | -18.7% | 0.14% | -25.0% |
| Q1 2014 | $449,008,000 | +2.6% | 6,102,317 | -3.0% | 0.19% | +1.1% |
| Q4 2013 | $437,645,000 | -0.7% | 6,292,537 | -6.2% | 0.19% | -10.6% |
| Q3 2013 | $440,866,000 | +6.9% | 6,711,294 | +12.7% | 0.21% | 0.0% |
| Q2 2013 | $412,516,000 | – | 5,955,184 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |